Home » N6-methyladenosine-modified TRIM37 augments sunitinib resistance by promoting the ubiquitin-degradation of SmARCC2 and activating the Wnt signaling pathway in renal cell carcinoma
N6-methyladenosine-modified TRIM37 augments sunitinib resistance by promoting the ubiquitin-degradation of SmARCC2 and activating the Wnt signaling pathway in renal cell carcinoma
by Pan, Yihui, Liu, Shuang, Shu, Guannan, Chen, Minyu, Fu, Liangmin, Chen, Cheng, Chen, Yimeng, Zhuang, Qianfeng, Xue, Dong & He, Xiaozhou | Feb 23, 2025 | Articles |
